Cerulean Pharma Inc. CERU
No live quote for CERU yet.
Valuation
P/E 0.0×
FY 2024 5y median 0.0× FY 2025
P/S 0.0×
FY 2024 5y median 0.0× FY 2025
P/B 0.0×
FY 2024 5y median 0.0× FY 2025
P/FCF 0.0×
FY 2024 5y median 0.0× FY 2025
EV/EBITDA -13.5×
FY 2024 5y median -5.0× FY 2025
EV/Sales -21.4×
FY 2024 5y median -746× FY 2025
FCF Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Profitability
Gross Margin 71.3%
FY 2024 5y median 35.6% FY 2025
Operating Margin -1315.5%
FY 2024 5y median -120503.9% FY 2025
Net Margin -1300.7%
FY 2024 5y median -21365.8% FY 2025
ROE -471.4%
FY 2024 5y median -202.0% FY 2025
ROIC -124.5%
FY 2024 5y median -1188.9% FY 2025
ROA -41.3%
FY 2024 5y median -29.8% FY 2025
Growth (YoY)
Revenue 10429.4%
FY 2024 FY 2025
Operating Income 42.2%
FY 2024 FY 2025
EPS (diluted) -150.0%
FY 2024 FY 2025
Free Cash Flow -313.0%
FY 2024 FY 2025
Financial Health
Current Ratio 1.1×
FY 2024 5y median 1.0× FY 2025
Quick Ratio 1.1×
FY 2024 5y median 1.0× FY 2025
Debt / Equity 0.9×
FY 2024 5y median 0.4× FY 2025
Net Debt / EBITDA -13.5×
FY 2024 5y median -5.0× FY 2025
Interest Coverage 0.0×
FY 2024 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31